1Freeman DJ,Norrie J,Caslake MJ,et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study[J]. Diabetes, 2002,51(5) : 1596-1600.
2Timpson NJ, Lawlor DA, Harbord RM, et al. C-reactive protein and its role in metabolic syndrome mendelian randomisation study[J]. Lancet, 2005,366(9501) : 1954-1959.
3Alexandraki K, Piperi C, Kalofoutis C, et al. Inflammatory process in type 2 diabetes.. The role of cytokines[J]. Annals, 2006,1084 (11):89-117.
4Winkler G,Lakatos P, Salamon F, et al. Elevated serum TNF-levels as a link between endothelial dysfunction and insulin resistance in normotensive obese subieets[J]. Diabet Med, 1999, 16(3):207-211.
3Mojiminiyi OA,Abdella N,Moussa MA,et al.Association of C reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus[J].Diabetes Res Clin Pract,2002,58(1):37-44.
4Volanakis JE.Human C reactive protein:expression,structure,and function[J].Mol Immunol,2001,38(23):189-197.
7Ridker PM,Cushman M,Stampfer MJ,et al.Inflammation,aspirin and the risk of cardiovascular disease in apparently healthy men[J].N Engl J Med,1997,336(5):973-979.
8Nader R,Russell P,Paul M,et al.Clinical efficacy of automated high-sensitivity C-reactive protein assay[J].Clin Chem,1999,12(12):2136-2141.
9Taniguchi A,Nagasaka S,Fujushima M,et al.C-reactive protein and insulin resistance in non-obese Japanese type 2 diabetic patients[J].Metabolism,2002,51(12):1578-1581.
10Abu-Lebdeh HS,Hodge DO,Nguyent TT.Predictors of macrovascular disease in patients with type 2 diabete mellitus[J].Mayo Clin Proc,2001,76(7):707-712.
